Quantum Private Wealth’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$650K Sell
90,231
-4,000
-4% -$25.7K 0.2% 79
2025
Q4
$531K Hold
94,231
0.16% 94
2025
Q3
$581K Buy
94,231
+3,500
+4% +$20.5K 0.17% 90
2025
Q2
$442K Buy
90,731
+19,898
+28% +$70.3K 0.14% 107
2025
Q1
$262K Buy
70,833
+13,500
+24% +$57.8K 0.1% 142
2024
Q4
$229K Buy
57,333
+25,800
+82% +$142K 0.07% 162
2024
Q3
$220K Buy
+31,533
New +$256K 0.07% 169
2022
Q4
Sell
-2,691
Closed -$18K 196
2022
Q3
$18K Buy
2,691
+206
+8% +$2.08K 0.01% 180
2022
Q2
$22K Sell
2,485
-440
-15% -$4.57K 0.01% 181
2022
Q1
$52K Buy
2,925
+134
+5% +$2.36K 0.02% 195
2021
Q4
$73K Buy
+2,791
New +$85.3K 0.03% 202

Other funds holding SLDB

Quantum Private Wealth's SLDB Position: Q1 2026 in Review

Quantum Private Wealth reduced its Solid Biosciences (SLDB) stake by 4.2% in Q1 2026, selling an estimated $25.7K and leaving 90,231 shares worth $650K. The position accounts for 0.2% of the portfolio, ranked #79.

Quantum Private Wealth first reported a position in SLDB in Q4 2021 and has held it in 11 quarters since. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Quantum Private Wealth held 90,231 shares of Solid Biosciences worth $650K as of Q1 2026.
  • Quantum Private Wealth sold 4,000 Solid Biosciences shares in Q1 2026, an estimated $25.7K.
  • Solid Biosciences made up 0.2% of Quantum Private Wealth's portfolio in Q1 2026, its #79 holding.
  • Quantum Private Wealth first reported a position in Solid Biosciences in Q4 2021 and has held it in 11 quarters since.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Quantum Private Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.